Prosecution Insights
Last updated: October 02, 2026
Application No. 17/788,582

OIL-IN-WATER-TYPE EMULSIFIED COSMETIC

Non-Final OA §103§112
Filed
Jun 23, 2022
Priority
Dec 25, 2019 — JP 2019-234484 +2 more
Examiner
OLSEN, KAELEIGH ELIZABETH
Art Unit
1619
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
SHISEIDO Company, Ltd.
OA Round
5 (Non-Final)
50%
Grant Probability
Moderate
5-6
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
16 granted / 32 resolved
-10.0% vs TC avg
Strong +62% interview lift
Without
With
+61.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
43 currently pending
Career history
85
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
51.6%
+11.6% vs TC avg
§102
8.6%
-31.4% vs TC avg
§112
27.8%
-12.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 32 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 06/23/2026 has been entered. Formal Matters Receipt of Applicant’s response dated 06/23/2026 is acknowledged. Claims 1 and 7-9 are pending. Claims 2-6 are canceled. Claim 1 is amended. Claims 1 and 7-9 are under consideration in the instant Office action. REJECTION WITHDRAWN Claim Rejections - 35 USC § 103 The rejection of claims 1 and 7-9 under 35 USC 103 set forth in the Office action dated 03/23/2026 is hereby withdrawn in light of Applicant’s remarks dated 06/23/2026 and Applicant’s submitted declaration under 37 CFR 1.132 dated 06/23/2026. NEW GROUNDS OF OBJECTION/REJECTION Claim Objections Claim 1 is objected to because in line 16 “, based on the total amount of the oil content” should be added following “10% by mass or more” in order to improve claim readability and consistency. Claim 8 is objected to because “the at least one selected from the polar oil and the ultraviolet absorber” should be amended to “the at least one selected from a polar oil and an ultraviolet absorber” in order to improve claim readability and consistency. Claim 8 is objected to because in line 2 a comma should be inserted after “more” in order to improve claim readability and consistency. Appropriate correction is required. Claim Rejections - 35 USC § 112(b) The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1 and 7-9 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. (a) Claim 1 recites the limitation "the nonionic surfactant" in line 33 and spanning lines 33 and 34. There is insufficient antecedent basis for this limitation in the claim because claim 1 does not earlier recite “a nonionic surfactant”. Claims 7-9 are also rejected for depending from claim 1. The Examiner suggests amending both recitations of "the nonionic surfactant" in claim 1 to “the PEG (11) methyl ether dimethicone” in order to overcome this rejection. (b) Claim 1 is indefinite in the recitation of “the PEG (11) methyl ether dimethicone” spanning lines 42 and 43 because it is unclear whether this refers to the PEG (11) methyl ether dimethicone in the dispersion medium, the PEG (11) methyl ether dimethicone in the oil droplet, or the PEG (11) methyl ether dimethicone in the both of the dispersion medium and oil droplet. As written, one skilled in the art would not be reasonably apprised of the metes and bounds of the claims. Claims 7-9 are also rejected as being dependent on claim 1 without resolving the ambiguity of claim 1. Response to Applicant’s Arguments Applicant’s arguments and the declaration submitted under 37 CFR 1.132 dated 06/23/2026 have been considered and the rejection under 35 USC 103 set forth in the Office action dated 03/23/2026 has been withdrawn. Allowable Subject Matter Claims 1 and 7-9 would be allowable upon overcoming the claims objections and the rejections under 35 USC 112(b) set forth above. Pertinent Prior Art The following prior art made of record and not relied upon are considered pertinent to Applicant’s disclosure: (1) Nagare et al (US 2017/0202758 A1, published 07/20/2017) teach a similar oil-in-water emulsion to that claimed, however the hydrophobized metal oxide is present only in the oil phase. (2) Nagare (US 2017/0128352 A1, published 05/11/2017) teaches a similar oil-in-water emulsion to that claimed, however the hydrophobically treated powder is present only in the water phase. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KAELEIGH ELIZABETH OLSEN whose telephone number is (703)756-1962. The examiner can normally be reached M-F 8-5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Blanchard can be reached at (571)272-0827. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /K.E.O./Examiner, Art Unit 1619 /NICOLE P BABSON/Primary Examiner, Art Unit 1619
Read full office action

Prosecution Timeline

Show 12 earlier events
Mar 23, 2026
Final Rejection mailed — §103, §112
Jun 04, 2026
Interview Requested
Jun 10, 2026
Examiner Interview Summary
Jun 10, 2026
Applicant Interview (Telephonic)
Jun 23, 2026
Request for Continued Examination
Jun 23, 2026
Response after Non-Final Action
Jun 25, 2026
Response after Non-Final Action
Aug 26, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12733638
HPPD AND PPO AGROCHEMICAL FORMULATIONS CONTAINING DRIFT REDUCTION TECHNOLOGIES
3y 3m to grant Granted Sep 15, 2026
Patent 12721797
COMPOSITION FOR CARING FOR KERATIN MATERIALS AND USE THEREOF
4y 2m to grant Granted Sep 01, 2026
Patent 12629392
METHOD OF TREATING COVID-19 INFECTION USING SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE
3y 1m to grant Granted May 19, 2026
Patent 12599129
FORMULATION AND COMPOSITION WHICH PROMOTE TARGETED POLLINATION BY BEES TOWARDS BLUEBERRY CROPS AND RELATED METHODS
3y 7m to grant Granted Apr 14, 2026
Patent 12582116
AGRICULTURAL FORMULATIONS
3y 7m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
50%
Grant Probability
99%
With Interview (+61.5%)
3y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 32 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month